Article

The Hindu on 2022-01-25 16:04

Pfizer starts Omicron-specific COVID-19 vaccine trial

The trial will involve 1,420 people aged 18-55.

Related news

Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine CNN
Pfizer, BioNTech begin Omicron vaccine trial timesofisrael.com
China , Greece , Thessaloniki , Israel , United States
Pfizer-BioNTech Begins Clinical Trial of Omicron-Targeted Vaccine observer.com
South Africa , Germany
Pfizer and BioNTech launch Omicron vaccine trial israelnationalnews.com
Pfizer launches study of omicron-specific COVID-19 vaccine The Verge
Pfizer, BioNTech start clinical trial for vaccine targeting Omicron variant New York Post
HPfizer Vaccine Neutralizes Omicron With Three Shots hamodia.com
Germany , South Africa , China
Pfizer to launch trial of Omicron-targeted COVID vaccine Sydney Morning Herald
Israel , United States , New York
Omicron-specific vaccine will be ready by March, Pfizer CEO says CNN
North Carolina , Fort Bragg
Pfizer, BioNTech begin study of omicron-specific COVID vaccine The Fresno Bee
Germany
Pfizer starts making vaccine that targets both omicron and the original COVID virus The Japan Times
Germany , South Africa , San Francisco
Pfizer CEO: We’re working on COVID vaccine against Omicron timesofisrael.com
Jerusalem , Germany , Israel , South Africa , Greece
Moderna and Pfizer launch Omicron-specific COVID vaccine trials newatlas.com
Australia , Phase 2
Vaccine makers have plans to make Omicron-specific booster, says Fauci Sydney Morning Herald
Germany , United Kingdom , Minnesota , Hawaii , Colorado
EU regulator starts review of BioNTech-Pfizer vaccine timesofmalta.com
Malta , Argentina , South Africa , Brazil , United Kingdom
HPfizer CEO: Omicron Vaccine Ready by March hamodia.com
Israel
Pfizer begins testing Omicron vaccine in adults NZ Herald
Pfizer: Tweaked vaccine works against omicron Arkansas Online
Chester